½ÃÀ庸°í¼­
»óǰÄÚµå
1424987

¼¼°è ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå : ±¸¼º ¿ä¼Òº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À² ¿¹Ãø(2023-2030³â)

Recombinant DNA Technology Market, By Component, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: AnalystView Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® 287 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå ±Ô¸ð´Â 2022³â 7,334¾ï 1,300¸¸ ´Þ·¯·Î 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 6.5%·Î È®´ë

ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå - ½ÃÀå ¿ªÇÐ

ÀçÁ¶ÇÕ ÀǾàǰ ¹× Ä¡·áÁ¦ »ý»ê ¼ö¿ä Áõ°¡·Î ½ÃÀå ¼ö¿ä ÃËÁø

ÀçÁ¶ÇÕ ÀǾàǰ ¹× Ä¡·áÁ¦ ¼ö¿ä Áõ°¡¿¡ µû¸¥ ÀçÁ¶ÇÕ DNAÀÇ »ý»ê Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù. »ý¸í °øÇРȸ»ç¿Í Á¦¾à ȸ»ç´Â rDNA ¹æ¹ýÀ» Áúº´ °ü¸®ÀÇ ¸¹Àº ºÐ¾ß¿¡ Àû¿ëÇÏ´Â ¹æ¹ýÀ» ÀÌÇØÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. À̰ÍÀº ÁÖ·Î È®´ëµÇ´Â Ä¡·á ¼ö¿ä¿¡ ´ëÀÀÇÏ°í ¸¸¼º ÁúȯÀÇ ºÎ´ã Áõ°¡¿Í ½Î¿ì±â ¶§¹®ÀÔ´Ï´Ù. °ß°íÇÑ ¹ÙÀÌ¿À ÀǾàǰ ÆÄÀÌÇÁ¶óÀÎ, ƯÈ÷ ÀçÁ¶ÇÕ ´Ü¹éÁú ÆÄÀÌÇÁ¶óÀÎÀÇ Á¸Àç´Â ÀÌ ±â¼úÀÇ ÀÌ¿ëÀ» ÃËÁøÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. CRISPR/Cas9 ´ºÅ¬·¹¾ÆÁ¦, ZFN, TALENÀ» ÀÌ¿ëÇÑ rDNA ±â¼úÀ» ÀÌ¿ëÇÑ ÀçÁ¶ÇÕ Á¦Ç°ÀÇ °³¹ßÀº »ý¹°¿¡ ÀÇÇÑ Á¦ÇÑÀ» ¹ÞÁö ¾Ê°í ½±°í Á¤È®ÇÑ À¯ÀüÀÚ ÆíÁýÀ» °¡´ÉÇÏ°Ô Çϰí, ÀÌ ºÐ¾ßÀÇ È®´ë¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¾Ï, ´ç´¢º´, °¨¿°°ú °°Àº Àΰ£ÀÇ ½É°¢ÇÑ Áúº´À» Ä¡·áÇÏ´Â ¾÷°èÀÇ Áøº¸´Â ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Áß¿äÇÑ ¿ä¼ÒÀÇ ÀϺÎÀÔ´Ï´Ù. »õ·Î¿î ºÐÀÚ ÀÇÇÐ, À¯ÀüÀÚ Ä¡·á ¹× ¾à¹° °³¹ßÀ» À§ÇÑ Àå±â°£ ÀÛ¿ëÇÏ´Â Ä¡·á ´Ü¹éÁúÀÇ Ã¢ÃâÀº ¸ðµÎ ÀçÁ¶ÇÕ ±â¼úÀÇ Áøº¸·ÎºÎÅÍ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯Àü¼º Áúȯ °ü¸®ÀÇ °³¼±°ú ÁøÇà ÁßÀÎ ½ÃÀå °³Ã´Àº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®·Â

¿ì¸®ÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ °øÀ¯¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030³â)¿¡ ¾à 6.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÄÄÆ÷³ÍÆ®º°·Î, È¿À²ÀûÀÎ ´Ü¹éÁú ¹ßÇö ´É·ÂÀº ¹ßÇö ½Ã½ºÅÛ ºÎ¹®ÀÌ 2022³â¿¡ ÃÖ´ë ½ÃÀå Á¡À¯À²À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿ëµµº°·Î´Â ÀǾàǰÀ̳ª ¹é½Å µîÀÇ Áúȯ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Ä¿¼­ °Ç°­¡¤Áúȯ ºÐ¾ß°¡ 2022³âÀÇ ÁÖ¿ä ºÐ¾ß°¡ µÇ¾ú½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚ ºÎ¹®À» ±â¹ÝÀ¸·Î Á¦¾à ¹× »ý¸í °øÇÐ ±â¾÷ ºÎ¹®Àº ÁÖ·Î ÀǾàǰ °³¹ß ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó 2022³â ÁÖ¿ä ºÎ¹®¿´½À´Ï´Ù.

Áö¿ªº°·Î ºÏ¹Ì´Â 2022³â ÁÖ¿ä ¼öÀÍ¿øÀ̾ú½À´Ï´Ù.

ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

ÀçÁ¶ÇÕ DNA ±â¼ú ¼¼°è ½ÃÀåÀº ±¸¼º ¿ä¼Ò, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº ±¸¼º ¿ä¼Ò¿¡ µû¶ó µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ¹ßÇö ½Ã½ºÅÛ, Ŭ·Î´× º¤ÅÍ. °ïÃæÀ̳ª ¹ÚÅ׸®¾Æ¸¦ ÀÌ¿ëÇÑ DNA ¹ßÇöÀÇ Á¶»ç°¡ Ȱ¹ßÇØÁö°í ÀÖÀ¸¸ç, ÀÌ ºÐ¾ß ¼ö¿ä¿¡ ¹ÚÂ÷°¡ °É¸± °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ëµµº°·Î´Â °Ç°­¡¤Áúȯ, ½Äǰ ¹× ³ó¾÷, ȯ°æ, ±âŸ 4°¡Áö·Î ºÐ·ùµË´Ï´Ù. °Ç°­¡¤Áúȯ ºÐ¾ß°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È¿¡µµ ±× ¿ìÀ§¼ºÀ» À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¹é½Å, ÀǾàǰ, È¿¼Ò ´ëü¹° µîÀÇ Áúº´ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾ »ç¿ëÀÚº°·Î Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷, ¿¬±¸±â°ü, ±âŸ 3°¡Áö·Î ºÐ·ùµË´Ï´Ù. Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷ÀÌ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È¿¡µµ ±× ¿ìÀ§¼ºÀ» À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ½Å¾à °³¹ß Áß½ÃÀÇ °íÁ¶°¡ ÀÌ ºÐ¾ßÀÇ ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå - Áö¸®Àû ÅëÂû

Áö¸®ÀûÀ¸·Î, ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ÆÛÁ® ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ Àü°³ÇÏ´Â ±¹°¡¿¡ µû¶ó ´õ ³ª´¹´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì´Â ½ÃÀåÀ» µ¶Á¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¹Ì±¹Àº ºÏ¹Ì¿¡¼­ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÁö¸¸, ±× ÁÖµÈ ÀÌÀ¯´Â ´Ù¼öÀÇ ¹ÙÀÌ¿À ÀǾàǰ Á¦Á¶ ±â¾÷ÀÌ Á¸ÀçÇÏ°í ±â¼ú ÀÌ¿ëÀ» µÑ·¯½Ñ ´Ù¾çÇÑ À±¸®Àû, °úÇÐÀû ¹®Á¦¿¡ ´«À» µ¹¸®±â À§ÇÑ °­·ÂÇÑ ±ÔÁ¦±â°üÀÌ Á¸ÀçÇϱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ·Î ÀÎÇØ ƯÈ÷ ºÏ¹Ì¿¡¼­ ½ÃÀå È®´ë°¡ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå - °æÀï ±¸µµ -

ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀåÀº ±× Ư¼º»ó Àû´çÈ÷ ´ÜÆíÈ­µÇ¾î ÀÖ½À´Ï´Ù. ¸¹Àº »ý¸í °úÇÐ ºÐ¾ß¿¡¼­ ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇØ °¢ ȸ»ç´Â Á¦ÈÞ¸¦ ¸Î°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÃÀå °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇÑ Çö½ÇÀûÀÎ Àü¼ú·Î¼­ °¢»ç´Â ²÷ÀÓ¾øÀÌ »ý»ê ¼³ºñ¸¦ Áõ°­Çϰí ÀÖ½À´Ï´Ù. Àü·«¿¡´Â ÇÕº´, Àμö, Á¦ÈÞ, Á¦Ç° °³¹ß µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå °³¿ä

  • Á¶»ç ¹üÀ§
  • ½ÃÀå ÃßÁ¤ ¿¬µµ

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ºÐ¼®
  • °æÀï ÀλçÀÌÆ®

Á¦3Àå ÀçÁ¶ÇÕ DNA ±â¼úÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ÇâÈÄ ½ÃÀå µ¿Çâ

Á¦4Àå ÀçÁ¶ÇÕ DNA ±â¼ú »ê¾÷ Á¶»ç

  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ¼ºÀå Àü¸Á ¸ÊÇÎ
  • ±ÔÁ¦ ƲÀÇ ºÐ¼®

Á¦5Àå ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

  • COVID-19 ÀÌÀüÀÇ ¿µÇ⠺м®
  • COVID-19 ÀÌÈÄÀÇ ¿µÇ⠺м®

Á¦6Àå ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå »óȲ

  • ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â
  • ÁÖ¿ä Á¦Á¶¾÷üº° ºÐ¼® µ¥ÀÌÅÍ
    • ±âÁ¸ ±â¾÷ÀÇ ºÐ¼®
    • ½ÅÈï±â¾÷ÀÇ ºÐ¼®

Á¦7Àå ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå - ±¸¼º ¿ä¼Òº°

  • °³¿ä
    • ±¸¼º¿ä¼Òº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ¹ßÇö ½Ã½ºÅÛ
    • Ŭ·Î´× º¤ÅÍ

Á¦8Àå ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå - ¿ëµµº°

  • °³¿ä
    • ¿ëµµº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • °Ç°­ ¹× Áúº´
    • ½Äǰ ¹× ³ó¾÷
    • ȯ°æ
    • ±âŸ

Á¦9Àå ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå - ÃÖÁ¾ »ç¿ëÀÚº°

  • °³¿ä
    • ÃÖÁ¾ »ç¿ëÀÚº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
    • ¿¬±¸±â°ü
    • ±âŸ

Á¦10Àå ÀçÁ¶ÇÕ DNA ±â¼ú ½ÃÀå - Áö¿ªº°

  • ¼Ò°³
  • ºÏ¹Ì
    • °³¿ä
    • ºÏ¹ÌÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • °³¿ä
    • À¯·´ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ·¯½Ã¾Æ
    • ³×´ú¶õµå
    • ½º¿þµ§
    • Æú¶õµå
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
    • °³¿ä
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • Àεµ
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ű¹
    • Àεµ³×½Ã¾Æ
    • Çʸ®ÇÉ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • °³¿ä
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • °³¿ä
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ÅÍŰ
    • ¾ËÁ¦¸®
    • ÀÌÁýÆ®
    • ±âŸ

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÀçÁ¶ÇÕ DNA ±â¼ú »ê¾÷

  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • F. Hoffmann-La Roche Ltd.
    • Profacgen
    • Amgen Inc
    • Novartis AG
    • GenScript
    • Pfizer Inc
    • Novo Nordisk A/S
    • Eli Lilly and Company
    • Sanofi
    • Merck &Co., Inc.
    • Biogen
    • Biocon
    • GlaxoSmithKline plc
    • New England Biolabs
    • Cibus
    • Monsanto Company
    • Horizon Discovery Group PLC
    • Others

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

JHS 24.02.28

REPORT HIGHLIGHT

Recombinant DNA Technology Market size was valued at USD 733,413 Million in 2022, expanding at a CAGR of 6.5% from 2023 to 2030.

The use of recombinant DNA technology has transformed medicine and is steadily influencing clinical practice. By substituting healthy genes with damaged and ill ones, it has made illness treatment easier. It is anticipated that DNA technology will grow as related technologies, such genome editing in plant tissue engineering, become more widely used.

Recombinant DNA Technology Market- Market Dynamics

Increasing demand for production of recombinant drugs and therapeutics to propel market demand

Increasing production of recombinant DNA with the rise in demand for recombinant drugs and therapeutics to fuel the market growth. Biotech and pharmaceutical companies are working to understand how rDNA methods might be applied to many areas of disease control. This is primarily to keep up with the expanding demand for treatments and fight the rising burden of chronic diseases. The presence of a robust biopharmaceuticals pipeline, in particular, the recombinant proteins pipeline; is likely to drive the use of this technology. Development of recombinant products employing rDNA techniques accompanied by CRISPR/Cas9 nuclease, ZFN, and TALEN enabling easy & precise genome editing with no limitation by organisms is significantly responsible for the expansion of this field.

The industry's advancements in the treatment of serious human illnesses like cancer, diabetes, and infectious diseases are some of the key elements influencing the market's growth. Novel molecular medicine, gene therapy, and the creation of long-acting therapeutic proteins for drug development have all benefited from advances in recombinant technologies. Moreover, improvements in the management of genetic illnesses and ongoing developments are anticipated to bolster market growth over the forecast period.

Recombinant DNA Technology Market- Key Insights

As per the shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2023-2030)

Based on Component, expression system segment was predicted to show maximum market share in the year 2022, due to its efficient protein expression capabilities.

Based on Application segmentation, health & disease segment was the leading segment in 2022, due to major demand for disease treatment such as drugs, vaccines, etc.

Based on End-User segmentation, pharmaceutical & biotech companies' segment was the leading segment in 2022, mainly due to growing number of drug developments.

On the basis of region, North America was the leading revenue generator in 2022, owing to supportive government regulations.

Recombinant DNA Technology Market- Segmentation Analysis:

The Global Recombinant DNA Technology Market is segmented on the basis of Component, Application, End-User, and Region.

The market is divided into two categories based on Component: expression system, and cloning vector. The epoxy-based segment dominates the market. Growing research in DNA expressions with insects, bacteria is expected to spur segment demand.

The market is divided into four categories based on Application: health & disease, food & agriculture, environment, and others. The health & disease segment dominates the market and is likely to maintain its dominance during the forecast period. The rising demand for disease treatment such as vaccine, drugs, and enzymes replacements is thriving market growth.

The market is divided into three categories based on End-User: pharmaceutical & biotech companies, research institutes, and others. The pharmaceutical & biotech companies segment dominates the market and is likely to maintain its dominance during the forecast period. The rise in emphasis on new drug development is expected to contribute to segment growth.

Recombinant DNA Technology Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The United States has the biggest market share in North America, mostly owing to the home to a large number of biopharmaceutical manufacturing companies and has strong regulatory agencies in place to keep an eye on the various ethical and scientific issues surrounding the use of technology. It is anticipated that this will propel market expansion, particularly in North America.

Recombinant DNA Technology Market- Competitive Landscape:

Recombinant DNA technology market is moderately fragmented in nature. To provide their services in the many life science domains, market companies are forming cooperative alliances. Additionally, companies are constantly growing their production facilities as a practical tactic to maintain their competitiveness in the market. Some of the strategies include mergers & acquisition, collaboration, product development, etc.

Recent Developments:

In December 2022, Amgen Inc. an American transnational biopharmaceutical company acquired Horizon rectifiers plc. to expand their product line.

In March 2022, VBI Vaccines Inc. issued PreHevbrio a Recombinant Hepatitis B Vaccine in the United States for the forestallment of infection.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET KEY PLAYERS

  • F. Hoffmann-La Roche Ltd.
  • Profacgen
  • Amgen Inc
  • Novartis AG
  • GenScript
  • Pfizer Inc
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi
  • Merck & Co., Inc.
  • Biogen
  • Biocon
  • GlaxoSmithKline plc
  • New England Biolabs
  • Cibus
  • Monsanto Company
  • Horizon Discovery Group PLC
  • Others

GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET, BY COMPONENT

  • Expression System
  • Cloning Vector

GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET, BY APPLICATION

  • Health & disease
  • Food & agriculture
  • Environment
  • Others

GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET, BY END-USER

  • Pharmaceutical & biotech companies
  • Research institutes
  • Others

GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Recombinant DNA Technology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Recombinant DNA Technology Market Snippet by Component
    • 2.1.2. Recombinant DNA Technology Market Snippet by Application
    • 2.1.3. Recombinant DNA Technology Market Snippet by End-User
    • 2.1.4. Recombinant DNA Technology Market Snippet by Country
    • 2.1.5. Recombinant DNA Technology Market Snippet by Region
  • 2.2. Competitive Insights

3. Recombinant DNA Technology Key Market Trends

  • 3.1. Recombinant DNA Technology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Recombinant DNA Technology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Recombinant DNA Technology Market Opportunities
  • 3.4. Recombinant DNA Technology Market Future Trends

4. Recombinant DNA Technology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Recombinant DNA Technology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Recombinant DNA Technology Market Landscape

  • 6.1. Recombinant DNA Technology Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Recombinant DNA Technology Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2022 & 2030 (%)
    • 7.1.2. Expression System
    • 7.1.3. Cloning Vector

8. Recombinant DNA Technology Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Health & disease
    • 8.1.3. Food & agriculture
    • 8.1.4. Environment
    • 8.1.5. Others

9. Recombinant DNA Technology Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical & biotech companies
    • 9.1.3. Research institutes
    • 9.1.4. Others

10. Recombinant DNA Technology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Recombinant DNA Technology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Recombinant DNA Technology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Recombinant DNA Technology Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Recombinant DNA Technology Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Recombinant DNA Technology Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Recombinant DNA Technology Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd.
    • 11.2.2. Profacgen
    • 11.2.3. Amgen Inc
    • 11.2.4. Novartis AG
    • 11.2.5. GenScript
    • 11.2.6. Pfizer Inc
    • 11.2.7. Novo Nordisk A/S
    • 11.2.8. Eli Lilly and Company
    • 11.2.9. Sanofi
    • 11.2.10. Merck & Co., Inc.
    • 11.2.11. Biogen
    • 11.2.12. Biocon
    • 11.2.13. GlaxoSmithKline plc
    • 11.2.14. New England Biolabs
    • 11.2.15. Cibus
    • 11.2.16. Monsanto Company
    • 11.2.17. Horizon Discovery Group PLC
    • 11.2.18. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦